New Anti-Diabetes Agents offer Promise in the Fight against CVD

Article Figures & Data

Figures

  • Figure 1.

    Metabolic Components of Diabetes: ADA Treatment Recommendations.

    Reproduced with permission from EA Oral, MD.
  • Figure 2.

    CV Endpoints – Reported SAEs.

    Reproduced from Gaziano JM et al. Randomized clinical trial of quick–release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes. Diabetes Care 2010. Jul;33(7):1503–8. With permission from the American Diabetes Association.